RE:RE:RE:RE:RE:RE:RE:RE:TALKIntuitively recognition of an incrementally evolving business model by a few investors is quite different than a conscious medium or long term corporate strategic decision. Point is that howie has had little credibility on where or what this company is and where its going but rather seems pushed by whatever environmental factor is present. Like calliing our international SGLT2 molecule after Wanbang for example so the RoW can license a drug whose generic name is from a chinese company. Looks like howie had little control over anything; and changing his stance on upfronts and pretend its business as usual is naive and arrogant. But whatever the case, he better a least make some deal or the chinese investors will become the latest group of disappointed investors after NA and Germany.